Clinical trial
Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for…
NCT00296972 · University Health Network, Toronto, Other · Terminated
Key facts
| NCT number | NCT00296972 |
|---|---|
| Title | Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication |
| Official title | A Randomized, Multicenter, phaseIIIB, Two Arm Study Evaluating the Tolerability of Peginterferon Alfa-2a Plus Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection co-Infected With Human Immunodeficiency Virus Receiving HAART Versus Not Receiving HAART |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, HIV Infections |
| Intervention type | Drug |
| Interventions | peg interferon plus ribavirin |
| Enrollment | 100 |
| Start date | Jul 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Feb 27, 2006 |
| Last update posted | Apr 23, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: